RU2017139267A - Усовершенствованные способы выделения рекомбинантных белков - Google Patents

Усовершенствованные способы выделения рекомбинантных белков Download PDF

Info

Publication number
RU2017139267A
RU2017139267A RU2017139267A RU2017139267A RU2017139267A RU 2017139267 A RU2017139267 A RU 2017139267A RU 2017139267 A RU2017139267 A RU 2017139267A RU 2017139267 A RU2017139267 A RU 2017139267A RU 2017139267 A RU2017139267 A RU 2017139267A
Authority
RU
Russia
Prior art keywords
level
recombinant protein
host cell
prokaryotic host
homogenization
Prior art date
Application number
RU2017139267A
Other languages
English (en)
Russian (ru)
Inventor
Майкл У. ЛЕЙРД
Ричард СТ. ДЖОН
Джейн В. ГАНСОН
Ким КАЛЕАС
Дипа НАДАРАДЖА
Рэйчел АДАМС
Брэдли Р. СНЕДЕКОР
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of RU2017139267A publication Critical patent/RU2017139267A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2017139267A 2012-03-27 2013-03-14 Усовершенствованные способы выделения рекомбинантных белков RU2017139267A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261616297P 2012-03-27 2012-03-27
US61/616,297 2012-03-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014137554A Division RU2636353C2 (ru) 2012-03-27 2013-03-14 Усовершенствованные способы выделения рекобинантных белков

Publications (1)

Publication Number Publication Date
RU2017139267A true RU2017139267A (ru) 2019-02-12

Family

ID=48040433

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2017139267A RU2017139267A (ru) 2012-03-27 2013-03-14 Усовершенствованные способы выделения рекомбинантных белков
RU2014137554A RU2636353C2 (ru) 2012-03-27 2013-03-14 Усовершенствованные способы выделения рекобинантных белков

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2014137554A RU2636353C2 (ru) 2012-03-27 2013-03-14 Усовершенствованные способы выделения рекобинантных белков

Country Status (20)

Country Link
US (9) US20140080180A1 (enExample)
EP (1) EP2831261B1 (enExample)
JP (4) JP6225162B2 (enExample)
KR (2) KR102096678B1 (enExample)
CN (2) CN109880867A (enExample)
AR (2) AR090340A1 (enExample)
AU (3) AU2013240280A1 (enExample)
BR (1) BR112014023176B1 (enExample)
CA (2) CA3086730A1 (enExample)
ES (1) ES2654424T3 (enExample)
HR (1) HRP20171966T1 (enExample)
IL (1) IL234377B (enExample)
MX (3) MX365947B (enExample)
MY (1) MY171729A (enExample)
PL (1) PL2831261T3 (enExample)
RU (2) RU2017139267A (enExample)
SG (4) SG11201406112TA (enExample)
SI (1) SI2831261T1 (enExample)
WO (1) WO2013148249A1 (enExample)
ZA (1) ZA201406434B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201037B1 (en) 1986-01-28 2001-03-13 Ophthalmic Research Group International, Inc. Plastic lens composition and method for the production thereof
JP2019517272A (ja) * 2016-06-10 2019-06-24 ロンザ リミテッドLonza Limited タンパク質の安定化方法
KR102595048B1 (ko) * 2016-11-07 2023-10-26 씨젠 인크. 조작된-시스테인 캡의 분포
US20210024873A1 (en) * 2018-03-27 2021-01-28 Bristol-Myers Squibb Company Real-time monitoring of protein concentration using ultraviolet signal
FI3857237T3 (fi) * 2019-01-16 2023-05-03 Regeneron Pharma Disulfidisidosten luonnehtimismenetelmiä
CN109725088B (zh) * 2019-03-16 2021-05-18 丁立平 一种测定豆芽中2-萘甲酸及其衍生物的气相色谱-质谱联用法
CN110305903B (zh) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 重组人促卵泡激素及其制备方法
CN113155776A (zh) * 2021-04-29 2021-07-23 华东交通大学 一种柑桔最佳采收期预测方法
FR3146146A1 (fr) 2023-02-24 2024-08-30 Bgene Genetics Production d’acide 1-4-dihydroxy-2-naphtoïque par Escherichia coli

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036891B (en) 1978-12-05 1983-05-05 Windsor Smith C Change speed gear
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
WO1987002671A1 (en) 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2193136T3 (es) 1991-08-14 2003-11-01 Genentech Inc Variantes de inmunoglubina para receptores especificos de fc epsilon.
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
EP0656789B1 (en) 1992-08-21 1997-12-17 Genentech, Inc. Method for treating a lfa-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5714338A (en) 1993-12-10 1998-02-03 Genentech, Inc. Methods for diagnosis of allergy
EP0739214B1 (en) 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
EP0749488A1 (en) 1994-03-03 1996-12-27 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
AU6267896A (en) 1995-06-07 1996-12-30 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth oftumors
EP1297847A3 (en) 1996-01-23 2003-05-07 Genentech, Inc. Anti-CD18 antibodies in stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
KR100532178B1 (ko) 1996-11-27 2005-12-01 제넨테크, 인크. 인간화 항-CD11a 항체
ES2236634T3 (es) 1997-04-07 2005-07-16 Genentech, Inc. Anticuerpos anti-vegf.
ES2293682T5 (es) 1997-05-15 2011-11-17 Genentech, Inc. Anticuerpo anti-apo2.
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
DK1226177T3 (da) 1999-10-29 2008-10-06 Genentech Inc Antistofsammensætninger mod anti-prostata stamcelle-antigen (PSCA) og anvendelser deraf
US6946271B2 (en) * 2000-09-20 2005-09-20 Degussa Ag Nucleotide sequences which code for the menE gene
US6979556B2 (en) 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
PT1572744E (pt) 2002-12-16 2010-09-07 Genentech Inc Variantes de imunoglobulina e utilizações destas
KR101003344B1 (ko) * 2003-03-26 2010-12-23 메이지 데어리스 코포레이션 1,4-디히드록시-2-나프토산의 안정화 방법
US7785830B2 (en) * 2003-08-13 2010-08-31 Sandoz Ag Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
WO2005078115A1 (en) * 2004-02-04 2005-08-25 Merck & Co., Inc. Process for large scale production of plasmid dna by e. coli fermentation
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CN101115832A (zh) * 2004-11-26 2008-01-30 协和发酵工业株式会社 工业上有用的微生物
JP5383481B2 (ja) * 2006-05-05 2014-01-08 ガンガゲン インコーポレーテッド ファージに由来する抗微生物活性
JP5305615B2 (ja) * 2006-06-05 2013-10-02 株式会社Adeka メナキノンの新規生合成経路に関与するタンパク質の遺伝子群を利用したメナキノンの製造方法
WO2008008975A2 (en) * 2006-07-14 2008-01-17 Genentech, Inc. Refolding of recombinant proteins
WO2009009523A2 (en) * 2007-07-09 2009-01-15 Genentech, Inc. Prevention of disulfide bond reduction during recombinant production of polypeptides
CN101665798B (zh) * 2008-09-06 2012-11-21 浙江我武生物科技股份有限公司 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法
CN101503470A (zh) * 2008-09-27 2009-08-12 上海交通大学 rhDSL重组蛋白及其制备方法
JP2010088387A (ja) * 2008-10-10 2010-04-22 Waseda Univ 放線菌内で目的タンパク質を誘導発現可能なプロモーター

Also Published As

Publication number Publication date
AR090340A1 (es) 2014-11-05
KR20200037425A (ko) 2020-04-08
HK1207120A1 (en) 2016-01-22
US20200199639A1 (en) 2020-06-25
SI2831261T1 (en) 2018-01-31
EP2831261B1 (en) 2017-10-18
RU2014137554A (ru) 2016-05-20
SG10201912877SA (en) 2020-02-27
JP2020202849A (ja) 2020-12-24
MX365947B (es) 2019-06-19
CA2866753A1 (en) 2013-10-03
US20240158825A1 (en) 2024-05-16
BR112014023176A2 (pt) 2017-06-20
CA2866753C (en) 2020-09-22
KR102096678B1 (ko) 2020-04-02
AU2017202484B2 (en) 2019-06-13
US20180291411A1 (en) 2018-10-11
RU2636353C2 (ru) 2017-11-22
JP2018046825A (ja) 2018-03-29
SG11201406112TA (en) 2014-10-30
JP2015512259A (ja) 2015-04-27
MX2019007032A (es) 2019-08-16
MX2014011558A (es) 2014-11-14
ZA201406434B (en) 2017-08-30
US9765379B2 (en) 2017-09-19
MX2018007677A (es) 2020-11-12
SG10202007206WA (en) 2020-08-28
CN104350156A (zh) 2015-02-11
BR112014023176B1 (pt) 2021-09-28
AU2013240280A1 (en) 2014-10-16
EP2831261A1 (en) 2015-02-04
CN109880867A (zh) 2019-06-14
US20150225760A1 (en) 2015-08-13
JP6225162B2 (ja) 2017-11-01
WO2013148249A1 (en) 2013-10-03
AR116615A2 (es) 2021-05-26
MY171729A (en) 2019-10-25
AU2019226192A1 (en) 2019-09-26
US20140080180A1 (en) 2014-03-20
JP2019141049A (ja) 2019-08-29
IL234377B (en) 2021-01-31
PL2831261T3 (pl) 2018-04-30
HRP20171966T1 (hr) 2018-02-09
CA3086730A1 (en) 2013-10-03
AU2017202484A1 (en) 2017-05-04
KR20140148392A (ko) 2014-12-31
SG10201508420VA (en) 2015-11-27
US20250137027A1 (en) 2025-05-01
US20230069966A1 (en) 2023-03-09
CN104350156B (zh) 2019-04-02
ES2654424T3 (es) 2018-02-13
US20160130624A1 (en) 2016-05-12
US20210171997A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
RU2017139267A (ru) Усовершенствованные способы выделения рекомбинантных белков
Boock et al. Engineered microbial biofuel production and recovery under supercritical carbon dioxide
CN103981204B (zh) 一种有活性的金鱼Tgf2转座子重组转座酶蛋白的表达方法
FI4186920T3 (fi) Ultrapitkävaikutteisia insuliini-Fc-fuusioproteiineja ja käyttömenetelmiä
JP2015512259A5 (enExample)
MX2022010388A (es) Polipéptidos de la cápside y vectores de virus adenoasociado.
Ley et al. Multi‐omic profiling of EPO‐producing Chinese hamster ovary cell panel reveals metabolic adaptation to heterologous protein production
RU2008134484A (ru) Новые флуоресцентные белки и способы их применения
RU2012126328A (ru) Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка
EA201400192A1 (ru) Клетка, ферментирующая пентозы
Jiang et al. Induction of gene expression in bacteria at optimal growth temperatures
Greener et al. A novel multicopy suppressor of a groEL mutation includes two nested open reading frames transcribed from different promoters.
CN118240036A (zh) 极地细菌抗冻蛋白优化改造方法与功能应用
CN103232979B (zh) 一种发形霞水母硫氧还蛋白及其编码基因与应用
RU2011134436A (ru) Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, обладающей повышенной экспрессией генов каскада образования флагелл и клеточной подвижности
CN107723287B (zh) 一种增强丝蛋白生产制备的表达系统
Kelman Isotope Labeling of Biomolecules–Labeling Methods
WO2025123662A1 (zh) 制备甲酰胺嘧啶dna糖基化酶的方法
RU2017118157A (ru) Новая фитаза, способ ее получения и ее применение
CN105861221A (zh) 一种基于Dal80p为靶标抑制氨基甲酸乙酯形成的黄酒酿造方法
CN107988290A (zh) 一种提高谷胱甘肽累积量的生物方法
CN106434652B (zh) 一种适用于谷氨酸棒杆菌的外源启动子及其应用
CN110577935B (zh) 一种增强t4 dna连接酶原核表达的方法
TWI567197B (zh) 表現元件、表現卡匣、及含其之載體
CN103981206B (zh) 一种筛选高产苏氨酸菌株的方法

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20201116